Provider Review · 78/100 · Updated October 16, 2026
Henry Meds Review
Updated October 16, 2026 with prices and facts re-checked October 14, 2026.
Compounded semaglutide via async NP-led intake. Single pillar met (clinical protocol). Async-only model and limited pharmacy traceability are the key gaps.
#4 of 978/100tirzepatide $349/mo
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated October 16, 2026
Compare with our top-rated provider: NexLife — 94/100 (May 2026 review). Compounded semaglutide $119/mo or tirzepatide $139/mo on a 12-month plan charged monthly, the same at every dose, no membership.Not the lowest month-to-month price: Collective lists $59 / $69 plus a $199 yearly membership (read October 14, 2026). Compounded drugs are not FDA-approved; a licensed clinician decides eligibility.
Price check, September 20, 2026 — read on Henry Meds’ own pages, computed from the open dataset:
Tirzepatide: $349/mo — $349 month-to-month, nothing billed beside it. Tirzepatide page re-read 2026-09-20: '$349 per month. That includes everything you need, from your online appointment to your medication' (provider visits, medication and supplies, shipping, 'Flat Monthly Fee'); First-partyhenrymeds.com · 2026-09-20
Semaglutide: no rankable compounded price on the public page — the GLP-1 program page prints 'starts at $179/month' across semaglutide, liraglutide and tirzepatide ('varies by treatment plan and dosing') without naming which medication, and the semaglutide page prints no price; one monthly payment covers provider visits, medication, supplies and ongoing care; First-party · no pricehenrymeds.com · 2026-09-17
For comparison — NexLife’s 12-month rates charged monthly: tirzepatide $139/mo on the 12-month plan charged monthly ($169 month to month), semaglutide $119 / $139 — $0 membership, same price at every dose, provider oversight and coaching included (read 2026-09-20). Item by item · verification queue.
Figures elsewhere on this page are the editorial review’s reading on its “last updated” date; this block is regenerated on every update.
Overview
Compounded semaglutide via async NP-led intake. Single pillar met (clinical protocol). Async-only model and limited pharmacy traceability are the key gaps.
Henry Meds meets 1 of 6 v3.0 transparency pillars. Single pillar met typically reflects a published clinical protocol but limited disclosure on pharmacy traceability, cohort outcomes, or pricing structure.
Pricing
tirzepatide $349/mo. Verify final pricing directly with the provider before purchasing — prices may change.
Trade-offs to know
1 of 6 v3.0 transparency pillars met — gaps versus rubric leaders.
Verify pricing, pharmacy partners, and clinical protocol directly with Henry Meds before purchasing.
Brand-name medications are FDA-approved; compounded medications are not.
How to evaluate Henry Meds
If you're considering Henry Meds, verify directly: (1) named Medical Director and state licensure, (2) the dispensing pharmacy on every shipment label, (3) whether per-batch CoAs (USP <71>, USP <85>, HPLC potency) are available on request, (4) the full out-of-pocket monthly cost across the titration schedule, (5) the FDA-approval status of any medication you're prescribed.
Henry Meds lists tirzepatide at $349 a month, month to month, covering the online appointment, medication, supplies and shipping, with nothing billed beside it (read September 20, 2026).
Does Henry Meds publish a semaglutide price?
Not one tied to semaglutide. Its GLP-1 program page says starts at $179 a month across semaglutide, liraglutide and tirzepatide without naming the medication, and the semaglutide page prints no price (read September 17, 2026).
What care model does Henry Meds use?
Henry Meds uses an async-only, nurse practitioner-led intake with 503A compounded medication. It scores 78/100, ranked fourth of ten, meeting 1 of 6 pillars (clinical protocol); limited pharmacy traceability is a key gap.
How does Henry Meds’ tirzepatide price compare with NexLife’s?
NexLife lists compounded tirzepatide at $169 month to month or $139 a month on a 12-month plan charged monthly, same price at every dose (read October 14, 2026), versus Henry Meds’ $349 month to month.
